カテゴリー： QYResearch, 世界, 部品/材料

世界の製薬用セルロース粉末市場インサイト及び予測（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）

◆英語タイトル：Global Pharma Grade Cellulose Powder Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX01952）◆商品コード：QY22JLX01952
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：92
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、製薬用セルロース粉末のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に製薬用セルロース粉末の世界市場のxxx％を占める「かさ密度＜0.2」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医薬品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
製薬用セルロース粉末の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの製薬用セルロース粉末市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

製薬用セルロース粉末のグローバル主要企業には、J. RETTENMAIER & SÖHNE、CFF GmbH & Co. KG、International Fiber Corporation、SWEETENER SUPPLY CORPORATION、Juku Orchem Private、JELU-WERK J. Ehrler、Ankit Pulps & Boards、NB Entrepreneurs、Nippon Paper Industriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

製薬用セルロース粉末市場は、種類と用途によって区分されます。世界の製薬用セルロース粉末市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4

【用途別セグメント】
医薬品、ヘルスケア製品

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 製薬用セルロース粉末製品概要
- 種類別市場（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）
- 用途別市場（医薬品、ヘルスケア製品）
- 調査の目的
・エグゼクティブサマリー
- 世界の製薬用セルロース粉末販売量予測2017-2028
- 世界の製薬用セルロース粉末売上予測2017-2028
- 製薬用セルロース粉末の地域別販売量
- 製薬用セルロース粉末の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別製薬用セルロース粉末販売量
- 主要メーカー別製薬用セルロース粉末売上
- 主要メーカー別製薬用セルロース粉末価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）
- 製薬用セルロース粉末の種類別販売量
- 製薬用セルロース粉末の種類別売上
- 製薬用セルロース粉末の種類別価格
・用途別市場規模（医薬品、ヘルスケア製品）
- 製薬用セルロース粉末の用途別販売量
- 製薬用セルロース粉末の用途別売上
- 製薬用セルロース粉末の用途別価格
・北米市場
- 北米の製薬用セルロース粉末市場規模（種類別、用途別）
- 主要国別の製薬用セルロース粉末市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの製薬用セルロース粉末市場規模（種類別、用途別）
- 主要国別の製薬用セルロース粉末市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の製薬用セルロース粉末市場規模（種類別、用途別）
- 主要国別の製薬用セルロース粉末市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の製薬用セルロース粉末市場規模（種類別、用途別）
- 主要国別の製薬用セルロース粉末市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの製薬用セルロース粉末市場規模（種類別、用途別）
- 主要国別の製薬用セルロース粉末市場規模（トルコ、サウジアラビア）
・企業情報
J. RETTENMAIER & SÖHNE、CFF GmbH & Co. KG、International Fiber Corporation、SWEETENER SUPPLY CORPORATION、Juku Orchem Private、JELU-WERK J. Ehrler、Ankit Pulps & Boards、NB Entrepreneurs、Nippon Paper Industries
・産業チェーン及び販売チャネル分析
- 製薬用セルロース粉末の産業チェーン分析
- 製薬用セルロース粉末の原材料
- 製薬用セルロース粉末の生産プロセス
- 製薬用セルロース粉末の販売及びマーケティング
- 製薬用セルロース粉末の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 製薬用セルロース粉末の産業動向
- 製薬用セルロース粉末のマーケットドライバー
- 製薬用セルロース粉末の課題
- 製薬用セルロース粉末の阻害要因
・主な調査結果

Cellulose powder is a fine white or almost white odorless powder. It is chemically purified alpha cellulose converted to free flowing powder. Cellulose comes in various forms, each with a specific use and cellulose powder is one of form. It is insoluble in water and many other liquids. 
Market Analysis and Insights: Global Pharma Grade Cellulose Powder Market
Due to the COVID-19 pandemic, the global Pharma Grade Cellulose Powder market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Bulk Density ＜0.2 accounting for % of the Pharma Grade Cellulose Powder global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Drug segment is altered to an % CAGR throughout this forecast period.
China Pharma Grade Cellulose Powder market size is valued at US$ million in 2021, while the US and Europe Pharma Grade Cellulose Powder are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharma Grade Cellulose Powder landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Pharma Grade Cellulose Powder include J. RETTENMAIER & SÖHNE, CFF GmbH & Co. KG, International Fiber Corporation, SWEETENER SUPPLY CORPORATION, Juku Orchem Private, JELU-WERK J. Ehrler, Ankit Pulps & Boards, NB Entrepreneurs and Nippon Paper Industries. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Pharma Grade Cellulose Powder capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Pharma Grade Cellulose Powder by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Pharma Grade Cellulose Powder Scope and Segment
Pharma Grade Cellulose Powder market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pharma Grade Cellulose Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bulk Density ＜0.2
Bulk Density 0.2-0.4
Bulk Density ＞0.4
Segment by Application
Drug
Health Care Products
By Company
J. RETTENMAIER & SÖHNE
CFF GmbH & Co. KG
International Fiber Corporation
SWEETENER SUPPLY CORPORATION
Juku Orchem Private
JELU-WERK J. Ehrler
Ankit Pulps & Boards
NB Entrepreneurs
Nippon Paper Industries
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Pharma Grade Cellulose Powder Product Introduction
1.2 Market by Type
1.2.1 Global Pharma Grade Cellulose Powder Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Bulk Density ＜0.2
1.2.3 Bulk Density 0.2-0.4
1.2.4 Bulk Density ＞0.4
1.3 Market by Application
1.3.1 Global Pharma Grade Cellulose Powder Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Drug
1.3.3 Health Care Products
1.4 Study Objectives
1.5 Years Considered
2 Global Pharma Grade Cellulose Powder Production
2.1 Global Pharma Grade Cellulose Powder Production Capacity (2017-2028)
2.2 Global Pharma Grade Cellulose Powder Production by Region: 2017 VS 2021 VS 2028
2.3 Global Pharma Grade Cellulose Powder Production by Region
2.3.1 Global Pharma Grade Cellulose Powder Historic Production by Region (2017-2022)
2.3.2 Global Pharma Grade Cellulose Powder Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Pharma Grade Cellulose Powder Sales in Volume & Value Estimates and Forecasts
3.1 Global Pharma Grade Cellulose Powder Sales Estimates and Forecasts 2017-2028
3.2 Global Pharma Grade Cellulose Powder Revenue Estimates and Forecasts 2017-2028
3.3 Global Pharma Grade Cellulose Powder Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Pharma Grade Cellulose Powder Sales by Region
3.4.1 Global Pharma Grade Cellulose Powder Sales by Region (2017-2022)
3.4.2 Global Sales Pharma Grade Cellulose Powder by Region (2023-2028)
3.5 Global Pharma Grade Cellulose Powder Revenue by Region
3.5.1 Global Pharma Grade Cellulose Powder Revenue by Region (2017-2022)
3.5.2 Global Pharma Grade Cellulose Powder Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Pharma Grade Cellulose Powder Production Capacity by Manufacturers
4.2 Global Pharma Grade Cellulose Powder Sales by Manufacturers
4.2.1 Global Pharma Grade Cellulose Powder Sales by Manufacturers (2017-2022)
4.2.2 Global Pharma Grade Cellulose Powder Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma Grade Cellulose Powder in 2021
4.3 Global Pharma Grade Cellulose Powder Revenue by Manufacturers
4.3.1 Global Pharma Grade Cellulose Powder Revenue by Manufacturers (2017-2022)
4.3.2 Global Pharma Grade Cellulose Powder Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Pharma Grade Cellulose Powder Revenue in 2021
4.4 Global Pharma Grade Cellulose Powder Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Pharma Grade Cellulose Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Pharma Grade Cellulose Powder Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Pharma Grade Cellulose Powder Sales by Type
5.1.1 Global Pharma Grade Cellulose Powder Historical Sales by Type (2017-2022)
5.1.2 Global Pharma Grade Cellulose Powder Forecasted Sales by Type (2023-2028)
5.1.3 Global Pharma Grade Cellulose Powder Sales Market Share by Type (2017-2028)
5.2 Global Pharma Grade Cellulose Powder Revenue by Type
5.2.1 Global Pharma Grade Cellulose Powder Historical Revenue by Type (2017-2022)
5.2.2 Global Pharma Grade Cellulose Powder Forecasted Revenue by Type (2023-2028)
5.2.3 Global Pharma Grade Cellulose Powder Revenue Market Share by Type (2017-2028)
5.3 Global Pharma Grade Cellulose Powder Price by Type
5.3.1 Global Pharma Grade Cellulose Powder Price by Type (2017-2022)
5.3.2 Global Pharma Grade Cellulose Powder Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Pharma Grade Cellulose Powder Sales by Application
6.1.1 Global Pharma Grade Cellulose Powder Historical Sales by Application (2017-2022)
6.1.2 Global Pharma Grade Cellulose Powder Forecasted Sales by Application (2023-2028)
6.1.3 Global Pharma Grade Cellulose Powder Sales Market Share by Application (2017-2028)
6.2 Global Pharma Grade Cellulose Powder Revenue by Application
6.2.1 Global Pharma Grade Cellulose Powder Historical Revenue by Application (2017-2022)
6.2.2 Global Pharma Grade Cellulose Powder Forecasted Revenue by Application (2023-2028)
6.2.3 Global Pharma Grade Cellulose Powder Revenue Market Share by Application (2017-2028)
6.3 Global Pharma Grade Cellulose Powder Price by Application
6.3.1 Global Pharma Grade Cellulose Powder Price by Application (2017-2022)
6.3.2 Global Pharma Grade Cellulose Powder Price Forecast by Application (2023-2028)
7 North America
7.1 North America Pharma Grade Cellulose Powder Market Size by Type
7.1.1 North America Pharma Grade Cellulose Powder Sales by Type (2017-2028)
7.1.2 North America Pharma Grade Cellulose Powder Revenue by Type (2017-2028)
7.2 North America Pharma Grade Cellulose Powder Market Size by Application
7.2.1 North America Pharma Grade Cellulose Powder Sales by Application (2017-2028)
7.2.2 North America Pharma Grade Cellulose Powder Revenue by Application (2017-2028)
7.3 North America Pharma Grade Cellulose Powder Sales by Country
7.3.1 North America Pharma Grade Cellulose Powder Sales by Country (2017-2028)
7.3.2 North America Pharma Grade Cellulose Powder Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Pharma Grade Cellulose Powder Market Size by Type
8.1.1 Europe Pharma Grade Cellulose Powder Sales by Type (2017-2028)
8.1.2 Europe Pharma Grade Cellulose Powder Revenue by Type (2017-2028)
8.2 Europe Pharma Grade Cellulose Powder Market Size by Application
8.2.1 Europe Pharma Grade Cellulose Powder Sales by Application (2017-2028)
8.2.2 Europe Pharma Grade Cellulose Powder Revenue by Application (2017-2028)
8.3 Europe Pharma Grade Cellulose Powder Sales by Country
8.3.1 Europe Pharma Grade Cellulose Powder Sales by Country (2017-2028)
8.3.2 Europe Pharma Grade Cellulose Powder Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pharma Grade Cellulose Powder Market Size by Type
9.1.1 Asia Pacific Pharma Grade Cellulose Powder Sales by Type (2017-2028)
9.1.2 Asia Pacific Pharma Grade Cellulose Powder Revenue by Type (2017-2028)
9.2 Asia Pacific Pharma Grade Cellulose Powder Market Size by Application
9.2.1 Asia Pacific Pharma Grade Cellulose Powder Sales by Application (2017-2028)
9.2.2 Asia Pacific Pharma Grade Cellulose Powder Revenue by Application (2017-2028)
9.3 Asia Pacific Pharma Grade Cellulose Powder Sales by Region
9.3.1 Asia Pacific Pharma Grade Cellulose Powder Sales by Region (2017-2028)
9.3.2 Asia Pacific Pharma Grade Cellulose Powder Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Pharma Grade Cellulose Powder Market Size by Type
10.1.1 Latin America Pharma Grade Cellulose Powder Sales by Type (2017-2028)
10.1.2 Latin America Pharma Grade Cellulose Powder Revenue by Type (2017-2028)
10.2 Latin America Pharma Grade Cellulose Powder Market Size by Application
10.2.1 Latin America Pharma Grade Cellulose Powder Sales by Application (2017-2028)
10.2.2 Latin America Pharma Grade Cellulose Powder Revenue by Application (2017-2028)
10.3 Latin America Pharma Grade Cellulose Powder Sales by Country
10.3.1 Latin America Pharma Grade Cellulose Powder Sales by Country (2017-2028)
10.3.2 Latin America Pharma Grade Cellulose Powder Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pharma Grade Cellulose Powder Market Size by Type
11.1.1 Middle East and Africa Pharma Grade Cellulose Powder Sales by Type (2017-2028)
11.1.2 Middle East and Africa Pharma Grade Cellulose Powder Revenue by Type (2017-2028)
11.2 Middle East and Africa Pharma Grade Cellulose Powder Market Size by Application
11.2.1 Middle East and Africa Pharma Grade Cellulose Powder Sales by Application (2017-2028)
11.2.2 Middle East and Africa Pharma Grade Cellulose Powder Revenue by Application (2017-2028)
11.3 Middle East and Africa Pharma Grade Cellulose Powder Sales by Country
11.3.1 Middle East and Africa Pharma Grade Cellulose Powder Sales by Country (2017-2028)
11.3.2 Middle East and Africa Pharma Grade Cellulose Powder Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 J. RETTENMAIER & SÖHNE
12.1.1 J. RETTENMAIER & SÖHNE Corporation Information
12.1.2 J. RETTENMAIER & SÖHNE Overview
12.1.3 J. RETTENMAIER & SÖHNE Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 J. RETTENMAIER & SÖHNE Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 J. RETTENMAIER & SÖHNE Recent Developments
12.2 CFF GmbH & Co. KG
12.2.1 CFF GmbH & Co. KG Corporation Information
12.2.2 CFF GmbH & Co. KG Overview
12.2.3 CFF GmbH & Co. KG Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 CFF GmbH & Co. KG Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 CFF GmbH & Co. KG Recent Developments
12.3 International Fiber Corporation
12.3.1 International Fiber Corporation Corporation Information
12.3.2 International Fiber Corporation Overview
12.3.3 International Fiber Corporation Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 International Fiber Corporation Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 International Fiber Corporation Recent Developments
12.4 SWEETENER SUPPLY CORPORATION
12.4.1 SWEETENER SUPPLY CORPORATION Corporation Information
12.4.2 SWEETENER SUPPLY CORPORATION Overview
12.4.3 SWEETENER SUPPLY CORPORATION Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 SWEETENER SUPPLY CORPORATION Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 SWEETENER SUPPLY CORPORATION Recent Developments
12.5 Juku Orchem Private
12.5.1 Juku Orchem Private Corporation Information
12.5.2 Juku Orchem Private Overview
12.5.3 Juku Orchem Private Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Juku Orchem Private Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Juku Orchem Private Recent Developments
12.6 JELU-WERK J. Ehrler
12.6.1 JELU-WERK J. Ehrler Corporation Information
12.6.2 JELU-WERK J. Ehrler Overview
12.6.3 JELU-WERK J. Ehrler Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 JELU-WERK J. Ehrler Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 JELU-WERK J. Ehrler Recent Developments
12.7 Ankit Pulps & Boards
12.7.1 Ankit Pulps & Boards Corporation Information
12.7.2 Ankit Pulps & Boards Overview
12.7.3 Ankit Pulps & Boards Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Ankit Pulps & Boards Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Ankit Pulps & Boards Recent Developments
12.8 NB Entrepreneurs
12.8.1 NB Entrepreneurs Corporation Information
12.8.2 NB Entrepreneurs Overview
12.8.3 NB Entrepreneurs Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 NB Entrepreneurs Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 NB Entrepreneurs Recent Developments
12.9 Nippon Paper Industries
12.9.1 Nippon Paper Industries Corporation Information
12.9.2 Nippon Paper Industries Overview
12.9.3 Nippon Paper Industries Pharma Grade Cellulose Powder Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Nippon Paper Industries Pharma Grade Cellulose Powder Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Nippon Paper Industries Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Pharma Grade Cellulose Powder Industry Chain Analysis
13.2 Pharma Grade Cellulose Powder Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Pharma Grade Cellulose Powder Production Mode & Process
13.4 Pharma Grade Cellulose Powder Sales and Marketing
13.4.1 Pharma Grade Cellulose Powder Sales Channels
13.4.2 Pharma Grade Cellulose Powder Distributors
13.5 Pharma Grade Cellulose Powder Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Pharma Grade Cellulose Powder Industry Trends
14.2 Pharma Grade Cellulose Powder Market Drivers
14.3 Pharma Grade Cellulose Powder Market Challenges
14.4 Pharma Grade Cellulose Powder Market Restraints
15 Key Finding in The Global Pharma Grade Cellulose Powder Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の製薬用セルロース粉末市場インサイト及び予測（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）(Global Pharma Grade Cellulose Powder Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 化粧品用カルボキシメチルセルロースのグローバル市場展望 2023年-2029年：通常型、高粘度
  • 世界の繊維用カルボキシメチルセルロースナトリウム（CMC）市場インサイト及び予測（純度≥90%以上、純度≥95%以上）
  • 世界の食品用セルロース粉末市場インサイト及び予測（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）
  • 世界の食品用アルファセルロース市場インサイト及び予測（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）
  • 世界の化粧品用セルロースパウダー市場インサイト及び予測（かさ密度＜0.2、かさ密度0.2〜0.4、かさ密度＞ 0.4）